Cargando…
A microbiome case-control study of recurrent acute otitis media identified potentially protective bacterial genera
BACKGROUND: Recurrent acute otitis media (rAOM, recurrent ear infection) is a common childhood disease caused by bacteria termed otopathogens, for which current treatments have limited effectiveness. Generic probiotic therapies have shown promise, but seem to lack specificity. We hypothesised that h...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819196/ https://www.ncbi.nlm.nih.gov/pubmed/29458340 http://dx.doi.org/10.1186/s12866-018-1154-3 |
_version_ | 1783301163099095040 |
---|---|
author | Lappan, Rachael Imbrogno, Kara Sikazwe, Chisha Anderson, Denise Mok, Danny Coates, Harvey Vijayasekaran, Shyan Bumbak, Paul Blyth, Christopher C. Jamieson, Sarra E. Peacock, Christopher S. |
author_facet | Lappan, Rachael Imbrogno, Kara Sikazwe, Chisha Anderson, Denise Mok, Danny Coates, Harvey Vijayasekaran, Shyan Bumbak, Paul Blyth, Christopher C. Jamieson, Sarra E. Peacock, Christopher S. |
author_sort | Lappan, Rachael |
collection | PubMed |
description | BACKGROUND: Recurrent acute otitis media (rAOM, recurrent ear infection) is a common childhood disease caused by bacteria termed otopathogens, for which current treatments have limited effectiveness. Generic probiotic therapies have shown promise, but seem to lack specificity. We hypothesised that healthy children with no history of AOM carry protective commensal bacteria that could be translated into a specific probiotic therapy to break the cycle of re-infection. We characterised the nasopharyngeal microbiome of these children (controls) in comparison to children with rAOM (cases) to identify potentially protective bacteria. As some children with rAOM do not appear to carry any of the known otopathogens, we also hypothesised that characterisation of the middle ear microbiome could identify novel otopathogens, which may also guide the development of more effective therapies. RESULTS: Middle ear fluids, middle ear rinses and ear canal swabs from the cases and nasopharyngeal swabs from both groups underwent 16S rRNA gene sequencing. The nasopharyngeal microbiomes of cases and controls were distinct. We observed a significantly higher abundance of Corynebacterium and Dolosigranulum in the nasopharynx of controls. Alloiococcus, Staphylococcus and Turicella were abundant in the middle ear and ear canal of cases, but were uncommon in the nasopharynx of both groups. Gemella and Neisseria were characteristic of the case nasopharynx, but were not prevalent in the middle ear. CONCLUSIONS: Corynebacterium and Dolosigranulum are characteristic of a healthy nasopharyngeal microbiome. Alloiococcus, Staphylococcus and Turicella are possible novel otopathogens, though their rarity in the nasopharynx and prevalence in the ear canal means that their role as normal aural flora cannot be ruled out. Gemella and Neisseria are unlikely to be novel otopathogens as they do not appear to colonise the middle ear in children with rAOM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12866-018-1154-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5819196 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58191962018-02-21 A microbiome case-control study of recurrent acute otitis media identified potentially protective bacterial genera Lappan, Rachael Imbrogno, Kara Sikazwe, Chisha Anderson, Denise Mok, Danny Coates, Harvey Vijayasekaran, Shyan Bumbak, Paul Blyth, Christopher C. Jamieson, Sarra E. Peacock, Christopher S. BMC Microbiol Research Article BACKGROUND: Recurrent acute otitis media (rAOM, recurrent ear infection) is a common childhood disease caused by bacteria termed otopathogens, for which current treatments have limited effectiveness. Generic probiotic therapies have shown promise, but seem to lack specificity. We hypothesised that healthy children with no history of AOM carry protective commensal bacteria that could be translated into a specific probiotic therapy to break the cycle of re-infection. We characterised the nasopharyngeal microbiome of these children (controls) in comparison to children with rAOM (cases) to identify potentially protective bacteria. As some children with rAOM do not appear to carry any of the known otopathogens, we also hypothesised that characterisation of the middle ear microbiome could identify novel otopathogens, which may also guide the development of more effective therapies. RESULTS: Middle ear fluids, middle ear rinses and ear canal swabs from the cases and nasopharyngeal swabs from both groups underwent 16S rRNA gene sequencing. The nasopharyngeal microbiomes of cases and controls were distinct. We observed a significantly higher abundance of Corynebacterium and Dolosigranulum in the nasopharynx of controls. Alloiococcus, Staphylococcus and Turicella were abundant in the middle ear and ear canal of cases, but were uncommon in the nasopharynx of both groups. Gemella and Neisseria were characteristic of the case nasopharynx, but were not prevalent in the middle ear. CONCLUSIONS: Corynebacterium and Dolosigranulum are characteristic of a healthy nasopharyngeal microbiome. Alloiococcus, Staphylococcus and Turicella are possible novel otopathogens, though their rarity in the nasopharynx and prevalence in the ear canal means that their role as normal aural flora cannot be ruled out. Gemella and Neisseria are unlikely to be novel otopathogens as they do not appear to colonise the middle ear in children with rAOM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12866-018-1154-3) contains supplementary material, which is available to authorized users. BioMed Central 2018-02-20 /pmc/articles/PMC5819196/ /pubmed/29458340 http://dx.doi.org/10.1186/s12866-018-1154-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Lappan, Rachael Imbrogno, Kara Sikazwe, Chisha Anderson, Denise Mok, Danny Coates, Harvey Vijayasekaran, Shyan Bumbak, Paul Blyth, Christopher C. Jamieson, Sarra E. Peacock, Christopher S. A microbiome case-control study of recurrent acute otitis media identified potentially protective bacterial genera |
title | A microbiome case-control study of recurrent acute otitis media identified potentially protective bacterial genera |
title_full | A microbiome case-control study of recurrent acute otitis media identified potentially protective bacterial genera |
title_fullStr | A microbiome case-control study of recurrent acute otitis media identified potentially protective bacterial genera |
title_full_unstemmed | A microbiome case-control study of recurrent acute otitis media identified potentially protective bacterial genera |
title_short | A microbiome case-control study of recurrent acute otitis media identified potentially protective bacterial genera |
title_sort | microbiome case-control study of recurrent acute otitis media identified potentially protective bacterial genera |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819196/ https://www.ncbi.nlm.nih.gov/pubmed/29458340 http://dx.doi.org/10.1186/s12866-018-1154-3 |
work_keys_str_mv | AT lappanrachael amicrobiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT imbrognokara amicrobiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT sikazwechisha amicrobiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT andersondenise amicrobiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT mokdanny amicrobiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT coatesharvey amicrobiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT vijayasekaranshyan amicrobiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT bumbakpaul amicrobiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT blythchristopherc amicrobiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT jamiesonsarrae amicrobiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT peacockchristophers amicrobiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT lappanrachael microbiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT imbrognokara microbiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT sikazwechisha microbiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT andersondenise microbiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT mokdanny microbiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT coatesharvey microbiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT vijayasekaranshyan microbiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT bumbakpaul microbiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT blythchristopherc microbiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT jamiesonsarrae microbiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera AT peacockchristophers microbiomecasecontrolstudyofrecurrentacuteotitismediaidentifiedpotentiallyprotectivebacterialgenera |